In recent years, scientists, clinicians and pharmaceutical companies have struggled to find new antibiotics or alternative strategies against multi-drug resistant bacteria that represent a serious public health problem. In a breakthrough study now published in PLOS Biology, Isabel Gordo and her team at Instituto Gulbenkian de Ciência (IGC; Portugal) identified a compensatory mechanism in bacteria that might be used in future therapies against multi-drug resistant bacteria.